Exploring treatments for drooling in children with neurological disorders

References

• Hockstein NG, Samadi DS, Gendron K, et al. Sialorrhea: a management challenge. Am Fam Physician. 2004 Jun 1;69(11):2628–2634.
   PubMed Web of Science ®Google Scholar
• Challenges in managing drooling in children. Drug Ther Bull. 2015 Jun;53(6):66–68.
   PubMedGoogle Scholar
• Dias BL, Fernandes AR, Maia Filho HDS, et al. Sialorrhea in children with cerebral palsy. J Pediatr (Rio J). 2016 Nov-Dec;92(6):549–558.
   PubMed Web of Science ®Google Scholar
• Chang SC, Lin CK, Tung LC, et al. The association of drooling and health-related quality of life in children with cerebral palsy. Neuropsychiatr Dis Treat. 2012;8:599–604.
   PubMed Web of Science ®Google Scholar
• Speyer R, Cordier R, Kim JH, et al. Prevalence of drooling, swallowing, and feeding problems in cerebral palsy across the lifespan: a systematic review and meta-analyses. Dev Med Child Neurol. 2019 Nov;61(11):1249–1258.
   PubMed Web of Science ®Google Scholar
• Sewell MD, Eastwood DM, Wimalasundera N, et al. M in children. BMJ. 2014 Sep;349:g5474.
   PubMed Web of Science ®Google Scholar
• Erasmus CE, Van Hulst K, Rotteveel LJ, et al. Drooling in cerebral palsy: hypersalivation or dysfunctional oral motor control? Dev Med Child Neurol. 2009 Jun;51(6):454–459.
   PubMed Web of Science ®Google Scholar
• Dravet C. The core Dravet syndrome phenotype. Epilepsia. 2011 Apr;52(Suppl 2):3–9.
   PubMedGoogle Scholar
• Gataullina S, Dulac O. From genotype to phenotype in Dravet disease. Seizure. 2017 Jan;44:58–64.
   PubMed Web of Science ®Google Scholar
• Clarke A. Rett syndrome. J Med Genet. 1996 Aug;33(8):693–699.
   PubMed Web of Science ®Google Scholar
• Gold WA, Krishnarajy R, Ellaway C, et al. Rett syndrome: a genetic update and clinical review focusing on comorbidities. ACS Chem Neurosci. 2018 Feb 21;9(2):167–176.
   PubMed Web of Science ®Google Scholar
• Neul JL, Kaufmann WE, Glaze DG, et al. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol. 2010 Dec;68(6):944–950.
   PubMed Web of Science ®Google Scholar
• Bernardo P, Raiano E, Cappuccio G, et al. The Treatment of Hypersalivation in Rett Syndrome with Botulinum Toxin: efficacy and Clinical Implications. Neurol Ther. 2019 Jun;8(1):155–160.
   PubMed Web of Science ®Google Scholar
• Fuertes-González MC, Silvestre FJ. Oral health in a group of patients with Rett syndrome in the regions of Valencia and Murcia (Spain): A case-control study. Med Oral Patol Oral Cir Bucal. 2014 Nov;19(6):e598–e604.
   PubMed Web of Science ®Google Scholar
• Bogusiak K, Puch A, Arkuszewski P. Goldenhar syndrome: current perspectives. World J Pediatr. 2017 Oct;13(5):405–415.
   PubMed Web of Science ®Google Scholar
• Passi S, Sharma N. Goldenhar syndrome. Indian J Dent Res. 2013 Jan-Feb;24(1):149.
   PubMedGoogle Scholar
• Bogusiak K, Arkuszewski P, Skorek-Stachnik K. Treatment strategy in Goldenhar syndrome. J Craniofac Surg. 2014 Jan;25(1):177–183.
   PubMed Web of Science ®Google Scholar
• Ei Hsu Hlaing E, Ishihara Y, Hara C, et al. Modification of Dentofacial Growth Associated with Goldenhar Syndrome. Acta Med Okayama. 2017 Oct;71(5):437–443.
   PubMed Web of Science ®Google Scholar
• Buiting K, Williams C, Horsthemke B. Angelman syndrome — insights into a rare neurogenetic disorder. Nat Rev Neurol. 2016 Oct;12(10):584–593.
   PubMed Web of Science ®Google Scholar
• Thibert RL, Larson AM, Hsieh DT, et al. Neurologic manifestations of Angelman syndrome. Pediatr Neurol. 2013 Apr;48(4):271–279.
   PubMed Web of Science ®Google Scholar
• Sochaniwskyj AE. Drool quantification: noninvasive technique. Arch Phys Med Rehabil. 1982 Dec;63(12):605–607.
   PubMed Web of Science ®Google Scholar
• van Hulst K, Lindeboom R, van der BURG J, et al. Accurate assessment of drooling severity with the 5-minute drooling quotient in children with developmental disabilities. Dev Med Child Neurol. 2012 Dec;54(12):1121–1126.
   PubMed Web of Science ®Google Scholar
• Reid SM, Johnson HM, Reddihough DS. The Drooling Impact Scale: a measure of the impact of drooling in children with developmental disabilities. Dev Med Child Neurol. 2010 Feb;52(2):e23–8.
   PubMed Web of Science ®Google Scholar
• Ribeiro LB, Xerez DR, Maliska C, et al. Qualitative and quantitative scintigraphy in sialorrhea before and after botulinum toxin injection. The Laryngoscope. 2019 Nov;129(11):2521–2526.
   PubMed Web of Science ®Google Scholar
• Thomas-Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia. 1988;3(2):73–78.
   PubMedGoogle Scholar
• Garnock-Jones KP. Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions. Paediatr Drugs. 2012 Aug 1;14(4):263–269.
   PubMed Web of Science ®Google Scholar
• Hussein I, Kershaw A, Tahmassebi J, et al. The management of drooling in children and patients with mental and physical disabilities: A literature review. Int J Paediatr Dent. 1998 Mar;8(1):3–11.
   PubMedGoogle Scholar
• Limbrock GJ, Hoyer H, Scheying H. Drooling, chewing and swallowing dysfunctions in children with cerebral palsy: treatment according to Castillo-Morales. ASDC J Dent Child. 1990 Nov-Dec;57(6):445–451.
   PubMed Web of Science ®Google Scholar
• Carlstedt K, Henningsson G, Dahllöf G. A four-year longitudinal study of palatal plate therapy in children with Down syndrome: effects on oral motor function, articulation and communication preferences. Acta Odontol Scand. 2003 Feb;61(1):39–46.
   PubMed Web of Science ®Google Scholar
• Crysdale WS, Greenberg J, Koheil R, et al. The drooling patient: team evaluation and management. Int J Pediatr Otorhinolaryngol. 1985 Aug;9(3):241–248.
   PubMed Web of Science ®Google Scholar
• Harris MM, Dignam PF. A non-surgical method of reducing drooling in cerebral-palsied children. Dev Med Child Neurol. 1980 Jun;22(3):293–299.
   PubMed Web of Science ®Google Scholar
• Koheil R, Sochaniwskyj AE, Bablich K, et al. Biofeedback techniques and behavior modification in the conservative remediation of drooling by children with cerebral palsy. Dev Med Child Neurol. 1987 Feb;29(1):19–26.
   PubMed Web of Science ®Google Scholar
• Iammateo PA, Trombly C, Luecke L. The effect of mouth closure on drooling and speech. Am J Occup Ther. 1990;44:686–691.
   PubMed Web of Science ®Google Scholar
• Domaracki LS, Sisson LA. Decreasing drooling with oral motor stimulation in children with multiple disabilities. Am J Occup Ther. 1990 Aug;44(8):680–684.
   PubMed Web of Science ®Google Scholar
• Lancioni GE, Brouwer J, Coninx F. Automatic cueing to reduce drooling: a long-term follow-up with two mentally handicapped persons. J Behav Ther Exp Psuchiatry. 1994 Jun;25(2):149–152.
   PubMed Web of Science ®Google Scholar
• Pedersen AML, Pedersen AML, Sørensen CE. Salivary secretion in health and disease. J Oral Rehabil. 2018 Sep;45(9):730–746.
   PubMed Web of Science ®Google Scholar
• McGeachan AJ, Mcdermott CJ. Management of oral secretions in neurological disease. Pract Neurol. 2017 Apr;17(2):96–103.
   PubMedGoogle Scholar
• drugs.com
   Google Scholar
• Blasco PA, Stansbury JC. Glycopyrrolate treatment of chronic drooling. Arch Pediatr Adolesc Med. 1996 Sep;150(9):932–935.
   PubMedGoogle Scholar
• Stern LM. Preliminary study of glycopyrrolate in the management of drooling. J Paediatr Child Health. 1997 Feb;33(1):52.
   PubMed Web of Science ®Google Scholar
• Bachrach SJ, Walter RS, Trzcinski K. Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy. Clin Pediatr (Phila). 1998 Aug;37(8):485–490.
   PubMed Web of Science ®Google Scholar
• Mier RJ, Bachrach SJ, Lakin RC, et al. Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study. Arch Pediatr Adolesc Med. 2000 Dec;154(12):1214–1218.
   PubMedGoogle Scholar
• Parr JR, Todhunter E, Pennington L, et al. Drooling Reduction Intervention randomized trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability. Arch Dis Child. 2018 Apr;103(4):371–376.
   PubMed Web of Science ®Google Scholar
• Zeller RS, Lee HM, Cavanaugh PF. Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions. Ther Clin Risk Manag. 2012;8:15–23.
   PubMed Web of Science ®Google Scholar
• Zeller RS, Davidson J, Lee HM, et al. Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions. Ther Clin Risk Manag. 2012;8:25–32.
   PubMed Web of Science ®Google Scholar
• Reid SM, Westbury C, Guzys AT, et al. Anticholinergic medications for reducing drooling in children with developmental disability. Dev Med Child Neurol. 2020 Mar;62(3):346–353.
   PubMed Web of Science ®Google Scholar
• Foran PG, Mohammed N, Lisk GO, et al. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F as compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J Biol Chem. 2003 Jan 10;278(2):1363–1371.
   PubMed Web of Science ®Google Scholar
• Silvestre-Donat FJ, Silvestre-Rangil J. Drooling. Monogr Oral Sci. 2014;24:126–134.
   PubMedGoogle Scholar
• Breheret R, Bizon A, Jeufroy C. Laccourreye. Ultrasound-guided botulinum toxin injections for treatment of drooling. Eur Ann Otorhinolaryngol Head Neck Dis. 2011 Nov;128(5):224–229.
   PubMed Web of Science ®Google Scholar
• Rodwell K, Edwards P, Ware RS, et al. Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and neurodevelopmental disability: a systematic review. Dev Med Child Neurol. 2012 Nov;54(11):977–987.
   PubMed Web of Science ®Google Scholar
• Wilken B, Aslami B, Backes H. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B. Neuropediatrics. 2008;39(4):200–204.
   PubMed Web of Science ®Google Scholar
• Basciani M, Di Rienzo F, Fontana A, et al. Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses. Dev Med Child Neurol. 2011 Jun;53(6):559–564.
   PubMed Web of Science ®Google Scholar
• Khan WU, Islam A, Fu A, et al. Four-duct ligation for the treatment of sialorrhea in children. JAMA Otolaryngol Head Neck Surg. 2016;142(3):278–283.
   PubMed Web of Science ®Google Scholar
• Reed J, Mans CK, Brietzke SE. Surgical management of drooling: a meta-analysis. Arch Otolaryngol Head Neck Surg. 2009 Sep;135(9):924–931.
   PubMedGoogle Scholar
• Steffen A, Jost W, Bäumer T, et al. Hypersalivation: update of the German S2K guidline (AWMF) in short form. J Neural Transm (Vienna). 2019 Jul;126(7):853–862.
   PubMed Web of Science ®Google Scholar